These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14990422)

  • 21. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005.
    Datta SD; Koutsky LA; Ratelle S; Unger ER; Shlay J; McClain T; Weaver B; Kerndt P; Zenilman J; Hagensee M; Suhr CJ; Weinstock H
    Ann Intern Med; 2008 Apr; 148(7):493-500. PubMed ID: 18378945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.
    Tangka FK; Howard DH; Royalty J; Dalzell LP; Miller J; O'Hara BJ; Sabatino SA; Joseph K; Kenney K; Guy GP; Hall IJ
    Cancer Causes Control; 2015 May; 26(5):671-86. PubMed ID: 25783455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
    Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of cytology-based cervical cancer screening in rural Cameroon.
    Robyr R; Nazeer S; Vassilakos P; Matute JC; Sando Z; Halle G; Mbakop A; Campana A
    Acta Cytol; 2002; 46(6):1110-6. PubMed ID: 12462091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of cytology development on frequency of pre-cancerous lesions and cervical cancer in east Croatia, 1978-2001.
    Milojković M; Pajtler M
    Coll Antropol; 2004 Jun; 28(1):293-300. PubMed ID: 15636086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection.
    Massad LS; Pierce CB; Minkoff H; Watts DH; Darragh TM; Sanchez-Keeland L; Wright RL; Colie C; D'Souza G
    Int J Cancer; 2014 Apr; 134(8):1854-61. PubMed ID: 24170366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
    Nygård JF; Sauer T; Skjeldestad FE; Skare GB; Thoresen SØ
    Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Previous screening for cervical cancer among women with cytological and histological abnormalities].
    Rama C; Roteli-Martins C; Derchain S; Longatto-Filho A; Gontijo R; Sarian L; Syrjanen K; Ching T; Aldrighi J
    Rev Saude Publica; 2008 Jun; 42(3):411-9. PubMed ID: 18470363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
    N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of cervical smear abnormalities within 3 years of normal cytology.
    Sawaya GF; Kerlikowske K; Lee NC; Gildengorin G; Washington AE
    Obstet Gynecol; 2000 Aug; 96(2):219-23. PubMed ID: 10908766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
    Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
    Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on clinical management of HPV(+)/Pap(-) during cervical cancer screening].
    Huang AJ; Zhao Y; Zou XL; Yan J; Zhao C; Cui SH; Li YY; Ren LH; Li JR; Li MZ; Wang Y; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):745-750. PubMed ID: 29179269
    [No Abstract]   [Full Text] [Related]  

  • 40. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
    Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
    J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.